DOCSLIB.ORG

Invited Review Enzymes Involved in Purine Metabolism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Histol Histopathol (1999) 14: 1321-1340 Histology and 001: 10.14670/HH-14.1321 Histopathology http://www.hh.um.es From Cell Biology to Tissue Engineering Invited Review Enzymes involved in purine metabolism - A review of histochemical localization and functional implications Y. Moriwaki, T. Yamamoto and K. Higashino Third Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan Summary. Many enzymes are involved in the reactive oxygen species, while the extensive tissue biosynthesis, interconversion, and degradation of purine localization of xanthine dehydrogenase/oxidase suggests compounds. The exact function of these enzymes is still several other roles for this enzyme, including a unknown, but they seem to play important roles other protective barrier against bacterial infection by than in purine metabolism. To elucidate their functional producing either superoxide radicals or uric acid. roles, it is imperative to clarify their tissue distribution at Furthermore, an involvement in cellular proliferation the cellular or subcellular level. The present review and differentiation has been suggested. Urate oxidase is summarizes the currently available information about generally considered a liver-specific enzyme, except for their histochemical localization and proposed functions. bovines which possess this enzyme in the kidney. Urate In general, 5' -nucleotidase has been considered as a oxidase is exclusively located in the peroxisomes of fish, marker enzyme for the plasma membrane, and is frogs, and rats, but was lost in birds, some reptiles, and considered to be a key enzyme in the generation of primates during evolution. A histochemical demon­ adenosine, a potential vasodilator. However, from its stration of allantoin-degrading enzymes has not been wide range of localization in tissues it is also considered performed, but these enzymes have been located in to be related to the membrane movement of cells in the peroxisomes by sucrose density gradient centrifugation. transitional epithelium, cellular motile response, AMP deaminase activity is higher in skeletal muscle transport process, cellular growth, synthesis of fibrous than in any other tissues. AMP deaminase may be protein and calcification, lymphocyte activation, involved in a number of physiological processes, such as neurotransmission, and oxygen sensing mechanism. the conversion of adenine nucleotide to inosine or Adenosine deaminase (ADA) is present in all tissues in guanine nucleotide, stabilizing the adenyl ate energy mammals. Although the main function of ADA is the charge, and the reaction of the purine nucleotide cycle. development of the immune system in humans, it seems There are three distinct isozymes (A, B, C) with different to be associated with the differentiation of epithelial kinetic, physical, and immunological properties. cells and monocytes, neurotransmission, and mainte­ Isozymes A, B, C have been isolated from muscle, liver nance of gestation. Purine nucleoside phosphorylase (kidney), and heart tissue, respectively. In the muscle, (PNP) is generally considered as a cytosolic enzyme, but AMP deaminase isozymes exist in a different part, recently, mitochondrial PNP, a different protein from suggesting a multiple functional role of this enzyme. cytosolic PNP, was reported. PNP is also widely High hypoxanthine-guanine phosphoribosyltransferase expressed in human tissues. It is found in most tissues of (HGPRT) activity is found in some regions of a normal the body, but the highest activity is in peripheral blood adult human brain. However, very little is known granulocyte and lymphoid tissues. It is also related to the regarding the histochemical tissue localization of development of T-cell immunity in humans as is ADA. HGPRT. Immunohistochemical localization of its Moreover, its contribution to centriole replication and/or developmental expression suggests that HGPRT may not regulation of microtubule assembly has been suggested. be essential for purine nucleotide supplement in the Immunohistochemical localization of xanthine oxidase segmentation of brain cells, but may playa significant has been reported in various tissues from various animal role in the developing hippocampus. species. Xanthine oxidase has been suggested to be involved in the pathogenesis of post-ischemic Key words: Purine metabolism-related enzymes, Tissue reperfusion tissue injury through the generation of distribution, Histochemistry, Function Offprint requests to: Yuji Moriwaki, M.D., Third Department of Internal Medicine, Hyogo College of Medicine, Mukogawa·cho 1-1, Nishinomiya, Introduction Hyogo 663·8501 , Japan. Fax: 81 -798-45·6474. e-mail: tetsuya@hyo­ med.ac.jp There are two major pathways in purine ribo- 1322 Enzymes of the purine metabolism nucleotide biosynthesis and degradation (Fig. 1). One is adenylosuccinate synthetase, and adenylosuccinate lyase de novo purine synthesis, and the other is the purine (Goodman and Lowenstein, 1977). AMP is recycled to reutilizing pathway by which purine bases and IMP by the reaction of AMP deaminase. De­ nucleosides are salvaged to respective ribonucleotides. phosphorylation of AMP, IMP, xanthosine mono­ The pathway of de novo purine synthesis consists of 11 phosphate (XMP), and guanosine monophosphate enzymatic reactions, forming inosine monophosphate (GMP) is catalyzed by purine 5' -nucleotidase and (IMP) (Wyngaarden and Kelley, 1976). As the initial nonspecific phosphatases to adenosine, inosine, step, PRPP (5'-phosphoribosyl I-pyrophosphate) xanthosine, and guanosine (Fox, 1978). Adenosine is synthetase produces PRPP, a key substrate in de novo further degraded to inosine by adenosine deaminase purine synthesis (Wyngaarden and Kelley, 1976; Becker (ADA). Purine nucleoside phosphorylase (PNP) mainly and Kim, 1987), from Mg-adenosine triphosphate (ATP) cleaves the nucleosides inosine and guanosine to and ribose 5-phosphate. Then, amidophosphoribosyl­ hypoxanthine and guanine, respectively. The oxidation transferase catalyzes the condensation of PRPP with L­ of hypoxanthine to xanthine, and subsequently to uric glutamine to generate phosphoribosylamine. The acid, is catalyzed by xanthine oxidase. In humans and succeeding reactions in the de novo pathway are directed primates, uric acid is the end product of purine to the construction and closure of the purine ring (Palella catabolism. In lower vertebrates, however, uric acid and Fox, 1989). All synthesized purine compounds are further undergoes degradation to allantoin, allantoate, ultimately derived from inosine monophosphate (IMP). ureidoglycollate, urea, and finally NH3, by urate Three enzymes are involved in the purine nucleotide oxidase, allantoinase, allantoicase, ureidoglycollate cycle: adenosine monophosphate (AMP) deaminase, lyase, and urease, respectively. The purine salvage ~ - ~ -I phosphoribosylamine 1-~ PRPP synthetase ATase GAR synthetase ~GAR transformytase IC-A'R 1- EJ - ~ - FGAR SAleM , AIR AIR synthetase FGAM synthetase synthetase carboxytase I S-AICAR I-I AICAR I-I FAICAR I AS lyase AK:AR transformytase f IMP cyclohydrolase IMP dehydrogenase GMP synthetase ~ - IAMP.s f- ~- ~-~ AS lyase AS synthetase f f AK t S'-ND S'-ND S'-ND • ,-------, ' ADA Fig. 1. Pathways in purine ribonucleotide biosynthesis, interconversion, and degradation. Abbreviations: ATase, amidophosphoribosyl­ transferase; AK, adenosine kinase; APRT, adenine phosphoribosyltransferase; HGPRT, hypoxanthine­ guanine phosphoribosyltransferase; S'-ND, S' ­ nucleotidase; ADA, adenosine deaminase; PNP, purine nucleoside phosphorylase; XO , xanthine oxidase; R-S-P, ribose-S-phosphate; PRPP, S'­ phosphoribosyl 1-pyrophosphate; GAR, S'- phospho­ ribosylglycineamide; FGAR, S'-phosphoribosyl N­ formylglycineamide; FGAM, S'-phosphoribosyl N­ formylglycineamidine; AIR, S'-phosphoribosyl-S­ aminoimidazole; C-AIR , S'-phosphoribosyl-S-amino-4- imidazole carboxylate; S-AICAR, S'-phosphoriboyl-S­ amino-4-imidazole·succinocarboxamide; AICAR, S'­ phosphoribosyl-S-amino-4-imidazolecarboxamide; FAICAR, S'-phosphoribosyl-S-formamido-4-imidazole­ carboxamide; IMP, inosine monophosphate; AMP, , ur ••s. adenosine monophosphate; AMP-S, adenylo­ succinate; XMP , xanthosine monophosphate; GMP, ~ guanosine monophosphate. 1323 Enzymes of the purine metabolism pathway involves hypoxanthine-guanine phospho­ method because of its lower nonspecific precipitate ribosyltransferase (HGPRT) which salvages hypo­ (Blok et aI., 1982; Robinson and Kamovsky, 1983). By xanthine and guanine to IMP, and adenine phosphoribo­ an enzyme-histochemical method using the cerium ion syltransferase (APRT) which salvages adenine to AMP technique, 5' -nucleotidase activity has been found on the (Wyngaarden and Kelley, 1976; Arnold, 1978). plasma membrane of all bladder transitional epithelial In recent years, some of the enzymes involved in cells, including the free surface of superficial cells, purine metabolism, especially in purine nucleotide suggesting that 5' -nucleotidase present on the luminal interconversion and catabolism, have been extensively surface of superficial cells plays a special role in the investigated with regard to their structures, substrate membrane movement of these cells in the transitional specificities, tissue and subcellular localization/ epithelium by accelerating actin polymerization (Zhang expression, molecular cloning, and regulation. Enzymes et aI., 1991). 5'-nucleotidase activity has also been involved in purine metabolism play an important role in shown in murine peritoneal resident macrophage
Recommended publications
  • United States Patent 19 11 Patent Number: 5,780,253 Subramanian Et Al

    United States Patent 19 11 Patent Number: 5,780,253 Subramanian Et Al

    III USOO5780253A United States Patent 19 11 Patent Number: 5,780,253 Subramanian et al. (45) Date of Patent: Jul. 14, 1998 54 SCREENING METHOD FOR DETECTION OF 4.433.999 2/1984 Hyzak ....................................... 71.03 HERBCDES 4.6–552 2/1987 Anoti et al. if O3. 4,802,912 2/1989 Baker ........................................ 7/103 Inventors: Wenkiteswaran Subramanian Danville: Anne G. Toschi. Burlingame. OTHERTHER PPUBLICATION CATIONS both of Calif. Heim et al. Pesticide Biochem & Physiol; vol. 53, pp. 138-145 (1995). 73) Assignee: Sandoz Ltd., Basel. Switzerland Hatch. MD.: Phytochem. vol. 6... pp. 115 to 119, (1967). Haworth et al. J. Agric. Food Chem, vol. 38, pp. 1271-1273. 21 Appl. No.:752.990 1990. Nishimura et al: Phytochem: vol. 34, pp. 613-615. (1993). 22 Filed: Nov. 21, 1996 Primary Examiner-Louise N. Leary Related U.S. Application Data Attorney, Agent, or Firm-Lynn Marcus-Wyner: Michael P. Morris 63 Continuation of Ser. No. 434.826, May 4, 1995, abandoned. 6 57 ABSTRACT 51 Int. Cl. ............................... C12Q 1/48: C12Q 1/32: C12Q 1/37; C12O 1/00 This invention relates to novel screening methods for iden 52 U.S. Cl. ................................. 435/15:435/18: 435/26: tifying compounds that specifically inhibit a biosynthetic 435/23: 435/4, 536/23.6:536/23.2:536/24.3 pathway in plants. Enzymes which are specifically affected 536/26.11:536/26.12:536/26.13 by the novel screening method include plant purine biosyn 58 Field of Search .................................. 435/15, 8, 26, thetic pathway enzymes and particularly the enzymes 435/23 4: 536/23.6, 23.2, 24.3, 26.1, involved in the conversion of inosine monophosphate to 26.12, 26.13 adenosine monophosphate and inosine monophosphate to guanosine monophosphate.
  • Nucleotide Degradation

    Nucleotide Degradation

    Nucleotide Degradation Nucleotide Degradation The Digestion Pathway • Ingestion of food always includes nucleic acids. • As you know from BI 421, the low pH of the stomach does not affect the polymer. • In the duodenum, zymogens are converted to nucleases and the nucleotides are converted to nucleosides by non-specific phosphatases or nucleotidases. nucleases • Only the non-ionic nucleosides are taken & phospho- diesterases up in the villi of the small intestine. Duodenum Non-specific phosphatases • In the cell, the first step is the release of nucleosides) the ribose sugar, most effectively done by a non-specific nucleoside phosphorylase to give ribose 1-phosphate (Rib1P) and the free bases. • Most ingested nucleic acids are degraded to Rib1P, purines, and pyrimidines. 1 Nucleotide Degradation: Overview Fate of Nucleic Acids: Once broken down to the nitrogenous bases they are either: Nucleotides 1. Salvaged for recycling into new nucleic acids (most cells; from internal, Pi not ingested, nucleic Nucleosides acids). Purine Nucleoside Pi aD-Rib 1-P (or Rib) 2. Oxidized (primarily in the Phosphorylase & intestine and liver) by first aD-dRib 1-P (or dRib) converting to nucleosides, Bases then to –Uric Acid (purines) –Acetyl-CoA & Purine & Pyrimidine Oxidation succinyl-CoA Salvage Pathway (pyrimidines) The Salvage Pathways are in competition with the de novo biosynthetic pathways, and are both ANABOLISM Nucleotide Degradation Catabolism of Purines Nucleotides: Nucleosides: Bases: 1. Dephosphorylation (via 5’-nucleotidase) 2. Deamination and hydrolysis of ribose lead to production of xanthine. 3. Hypoxanthine and xanthine are then oxidized into uric acid by xanthine oxidase. Spiders and other arachnids lack xanthine oxidase.
  • 35 Disorders of Purine and Pyrimidine Metabolism

    35 Disorders of Purine and Pyrimidine Metabolism

    35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP).
  • Generated by SRI International Pathway Tools Version 25.0, Authors S

    Generated by SRI International Pathway Tools Version 25.0, Authors S

    An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000238675-HmpCyc: Bacillus smithii 7_3_47FAA Cellular Overview Connections between pathways are omitted for legibility.
  • Metabolism of Purines and Pyrimidines in Health and Disease

    Metabolism of Purines and Pyrimidines in Health and Disease

    39th Meeting of the Polish Biochemical Society Gdañsk 16–20 September 2003 SESSION 6 Metabolism of purines and pyrimidines in health and disease Organized by A. C. Sk³adanowski, A. Guranowski 182 Session 6. Metabolism of purines and pyrimidines in health and disease 2003 323 Lecture The role of DNA methylation in cytotoxicity mechanism of adenosine analogues in treatment of leukemia Krystyna Fabianowska-Majewska Zak³ad Chemii Medycznej IFiB, Uniwersytet Medyczny, ul. Mazowiecka 6/8, 92 215 £ódŸ Changes in DNA methylation have been recognized tory effects of cladribine and fludarabine on DNA as one of the most common molecular alterations in hu- methylation, after 48 hr growth of K562 cells with the man neoplastic diseases and hypermethylation of drugs, are non-random and affect mainly CpG rich is- gene-promoter regions is one of the most frequent lands or CCGG sequences but do not affect sepa- mechanisms of the loss of gene functions. For this rea- rately-located CpG sequences. The analysis showed son, DNA methylation may be a tool for detection of that cladribine (0.1 mM) reduced the methylated early cell transformations as well as predisposition to cytosines in CpG islands and CCGG sequences to a sim- metastasis process. Moreover, DNA methylation seems ilar degree. The inhibition of cytosine methylation by to be a promissing target for new preventive and thera- fludarabine (3 mM) was observed mainly in CCGG se- peutic strategies. quences, sensitive to HpaII, but the decline in the meth- Our studies on DNA methylation and cytotoxicity ylated cytosine, located in CpG island was 2-fold lower mechanism of antileukemic drugs, cladribine and than that with cladribine.
  • Discovery of an Alternate Metabolic Pathway for Urea Synthesis in Adult Aedes Aegypti Mosquitoes

    Discovery of an Alternate Metabolic Pathway for Urea Synthesis in Adult Aedes Aegypti Mosquitoes

    Discovery of an alternate metabolic pathway for urea synthesis in adult Aedes aegypti mosquitoes Patricia Y. Scaraffia*†‡, Guanhong Tan§, Jun Isoe*†, Vicki H. Wysocki*§, Michael A. Wells*†, and Roger L. Miesfeld*† Departments of §Chemistry and *Biochemistry and Molecular Biophysics and †Center for Insect Science, University of Arizona, Tucson, AZ 85721-0088 Edited by Anthony A. James, University of California, Irvine, CA, and approved December 4, 2007 (received for review August 27, 2007) We demonstrate the presence of an alternate metabolic pathway We previously reported that mosquitoes dispose of toxic for urea synthesis in Aedes aegypti mosquitoes that converts uric ammonia through glutamine (Gln) and proline (Pro) synthesis, acid to urea via an amphibian-like uricolytic pathway. For these along with excretion of ammonia, uric acid, and urea (20). By studies, female mosquitoes were fed a sucrose solution containing using labeled isotopes and mass spectrometry techniques (21), 15 15 15 15 15 NH4Cl, [5- N]-glutamine, [ N]-proline, allantoin, or allantoic we have recently determined how the N from NH4Cl is acid. At 24 h after feeding, the feces were collected and analyzed incorporated into the amide side chain of Gln, and then into Pro, in a mass spectrometer. Specific enzyme inhibitors confirmed that in Ae. aegypti (22). In the present article we demonstrate that the 15 15 15 mosquitoes incorporate N from NH4Cl into [5- N]-glutamine nitrogen of the amide group of Gln contributes to uric acid and use the 15N of the amide group of glutamine to produce synthesis in mosquitoes and, surprisingly, that uric acid can be 15 labeled uric acid.
  • Yeast Genome Gazetteer P35-65

    Yeast Genome Gazetteer P35-65

    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
  • Determining HDAC8 Substrate Specificity by Noah Ariel Wolfson A

    Determining HDAC8 Substrate Specificity by Noah Ariel Wolfson A

    Determining HDAC8 substrate specificity by Noah Ariel Wolfson A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Biological Chemistry) in the University of Michigan 2014 Doctoral Committee: Professor Carol A. Fierke, Chair Professor Robert S. Fuller Professor Anna K. Mapp Associate Professor Patrick J. O’Brien Associate Professor Raymond C. Trievel Dedication My thesis is dedicated to all my family, mentors, and friends who made getting to this point possible. ii Table of Contents Dedication ....................................................................................................................................... ii List of Figures .............................................................................................................................. viii List of Tables .................................................................................................................................. x List of Appendices ......................................................................................................................... xi Abstract ......................................................................................................................................... xii Chapter 1 HDAC8 substrates: Histones and beyond ...................................................................... 1 Overview ..................................................................................................................................... 1 HDAC introduction
  • Table S1. List of Genes Up- Or Down-Regulated in H99 When Bound by 18B7

    Table S1. List of Genes Up- Or Down-Regulated in H99 When Bound by 18B7

    Table S1. List of genes up- or down-regulated in H99 when bound by 18B7. Up-regulated Genes Classification CNF03470: Formate dehydrogenase Metabolism CNC03960: Phosphate transporter, putative Metabolism CND00530: Putative urea transporter Secretion CNA02250: Ammonium transporter MEP1 Secretion CNC06440: Inositol 1-phosphate synthase Metabolism CND03490: Chitin deacetylase-like mannoprotein MP98 Cell wall CNA04560: Hypothetical protein Hypothetical CNF02180: Acetyl-CoA carboxylase, putative Metabolism CNJ00690: Uracil permease, putative Secretion CNF02510: Alcohol dehydrogenase, putative Metabolism CNE04360: Fatty acid synthase, alpha subunit-related Metabolism CNM00180: Cyclohydrolase, putative Metabolism CNL03740: AF540951 catalase isozyme P Stress CNE04370: Fatty acid synthase, beta subunit Metabolism CNA01790: Expressed protein Hypothetical CNA05700: Expressed protein Hypothetical CND03840: Vacuole fusion, non-autophagic-related protein, putative Cell wall CNM00980: Hypothetical protein Hypothetical CNI02420: Uricase (Urate oxidase), putative Metabolism CNJ01090: Xylitol dehydrogenase-related Cell wall CNC03430: Alpha-1,6-mannosyltransferase, putative Cell wall CNF04120: Expressed protein Hypothetical CNB01810: Short chain dehydrogenase, putative Metabolism CNJ01200: Hypothetical protein Hypothetical CNA01160: LSDR putative Metabolism CNH03430: Hypothetical protein Hypothetical CNM02410: Putative proteine disulfate isomerase Housekeeping CNG04200: Alpha-amylase, putative Cell wall CNC00920: NADP-dependent glutamate dehydrogenase Metabolism
  • Nucleotide Metabolism 22

    Nucleotide Metabolism 22

    Nucleotide Metabolism 22 For additional ancillary materials related to this chapter, please visit thePoint. I. OVERVIEW Ribonucleoside and deoxyribonucleoside phosphates (nucleotides) are essential for all cells. Without them, neither ribonucleic acid (RNA) nor deoxyribonucleic acid (DNA) can be produced, and, therefore, proteins cannot be synthesized or cells proliferate. Nucleotides also serve as carriers of activated intermediates in the synthesis of some carbohydrates, lipids, and conjugated proteins (for example, uridine diphosphate [UDP]-glucose and cytidine diphosphate [CDP]- choline) and are structural components of several essential coenzymes, such as coenzyme A, flavin adenine dinucleotide (FAD[H2]), nicotinamide adenine dinucleotide (NAD[H]), and nicotinamide adenine dinucleotide phosphate (NADP[H]). Nucleotides, such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), serve as second messengers in signal transduction pathways. In addition, nucleotides play an important role as energy sources in the cell. Finally, nucleotides are important regulatory compounds for many of the pathways of intermediary metabolism, inhibiting or activating key enzymes. The purine and pyrimidine bases found in nucleotides can be synthesized de novo or can be obtained through salvage pathways that allow the reuse of the preformed bases resulting from normal cell turnover. [Note: Little of the purines and pyrimidines supplied by diet is utilized and is degraded instead.] II. STRUCTURE Nucleotides are composed of a nitrogenous base; a pentose monosaccharide; and one, two, or three phosphate groups. The nitrogen-containing bases belong to two families of compounds: the purines and the pyrimidines. A. Purine and pyrimidine bases Both DNA and RNA contain the same purine bases: adenine (A) and guanine (G).
  • Nfletffillfl Sm of Nuelieotfl Dles

    Nfletffillfl Sm of Nuelieotfl Dles

    Nfletffillflsm of Nuelieotfl dles ucleotides \f consistof a nitrogenousbase, a | \ pentose and a phosphate. The pentose sugaris D-ribosein ribonucleotidesof RNAwhile in deoxyribonucleotides(deoxynucleotides) of i Aspariaie--'N.,,,t .J . DNA, the sugaris 2-deoxyD-ribose. Nucleotides t participate in almost all the biochemical processes/either directly or indirectly.They are the structuralcomponents of nucleicacids (DNA, Y RNA), coenzymes, and are involved in tne Glutamine regulationof severalmetabolic reactions. Fig. 17.1 : The sources of individuat atoms in purine ring. (Note : Same colours are used in the syntheticpathway Fig. lZ.2). n T. C4, C5 and N7 are contributedby glycine. Many compoundscontribute to the purine ring of the nucleotides(Fig.t7.l). 5. C6 directly comes from COr. 1. purine N1 of is derivedfrom amino group It should be rememberedthat purine bases of aspartate. are not synthesizedas such,but they are formed as ribonucleotides. The purines 2. C2 and Cs arise from formate of N10- are built upon a formyl THF. pre-existing ribose S-phosphate. Liver is the major site for purine nucleotide synthesis. 3. N3 and N9 are obtainedfrom amide group Erythrocytes,polymorphonuclear leukocytes and of glutamine. brain cannot producepurines. 388 BIOCHEMISTF|Y m-gg-o-=_ |l Formylglycinamide ribosyl S-phosphate Kn H) Glutam H \-Y OH +ATt OH OH Glutame cl-D-Ribose-S-phosphate + ADP orr-l t'1 PRPPsYnthetase ,N o"t*'] \cH + Hrcl-itl HN:C-- O EO-qn2-O.- H -NH l./ \l KH H) I u \.]_j^/ r,\-iEl-/^\-td Ribose5-P II Formylglycinamidineribosyl-s-phosphate
  • Arginase Specific Activity and Nitrogenous Excretion of Penaeus Japonicus Exposed to Elevated Ambient Ammonia

    Arginase Specific Activity and Nitrogenous Excretion of Penaeus Japonicus Exposed to Elevated Ambient Ammonia

    MARINE ECOLOGY PROGRESS SERIES Published July 10 Mar Ecol Prog Ser Arginase specific activity and nitrogenous excretion of Penaeus japonicus exposed to elevated ambient ammonia Jiann-Chu Chen*,Jiann-Min Chen Department of Aquaculture. National Taiwan Ocean University. Keelung, Taiwan 20224, Republic of China ABSTRACT: Mass-specific activity of arginase and nitrogenous excretion of Penaeus japonicus Bate (10.3 * 3.7 g) were measured for shrimps exposed to 0.029 (control), 1.007 and 10.054 mg 1-' ammonia- N at 32%, S for 24 h. Arginase specific activity of gill, hepatopancreas and midgut increased directly with ambient ammonia-N, whereas arginase specific activity of muscle was inversely related to ambient ammonia-N. Excretion of total-N (total nitrogen), organic-N and urea-N increased, whereas excretion of ammonia-N, nitrate-N and nitrite-N decreased significantly with an increase of ambient ammonia- N. In the control solution, japonlcus excreted 68.94% ammonia-N, 25.39% organic-N and 2.87% urea-N. For the shrimps exposed to 10 mg 1" ammonia-N, ammonia-N uptake occurred, and t.he con- tribution of organic-N and urea-N excretion increased to 90.57 and 8.78%, respectively, of total-N. High levels of arginase specific activity in the gill, midgut and hepatopancreas suggest that there is an alternative route of nitrogenous waste for P. japonicus under ammonia exposure. KEY WORDS: Penaeus japonicus - Ammonia . Arginase activity . Nitrogenous excretion . Metabolism INTRODUCTION processes. Therefore, accumulation of ammonia and its toxicity are of primary concern. Kuruma shrimp Penaeus japonicus Bate, which is Ammonia has been reported to increase molting fre- distributed in Pacific rim countries, is also found in the quency, reduce growth, and even cause mortality of Mediterranean.